Psychological symptoms during and after Austrian first lockdown in individuals with bipolar disorder? A follow-up control-group investigation
Tóm tắt
The coronavirus disease (COVID-19) pandemic, a global health crisis, has resulted in widespread socioeconomic restrictions including lockdown, social distancing, and self-isolation. To date, little is known about the psychological impact of the COVID-19 pandemic and lockdown on patients with bipolar disorder as a particularly vulnerable group. An online survey was conducted in Austria at two points of measurement (T1 April 2020 during the first lockdown vs. T2 May 2020 at post-lockdown). The sample comprises 20 patients with bipolar disorder (mean age = 49.4 ± 15.6 years) and 20 healthy controls (mean age = 32.7 ± 9.6 years). A 2 × 2 factorial design to compare two time points (T1 vs. T2) and two groups (patients vs. healthy controls) was used. Main outcome measures included the Brief Symptom Inventory-18 (BSI-18) and a (non-validated and non-standardized) assessment to determine COVID-19 fears and emotional distress due to social distancing. Multiple linear regression analyses were used to assess the longitudinal association of COVID-19 fears/emotional distress due to social distancing during lockdown (T1) and psychological symptoms after lockdown (T2). At T1, results demonstrated higher scores in BSI-18 subscales depression, anxiety and global severity index as well as emotional distress due to social distancing in bipolar patients compared to controls. There was a significant time x group interaction in the BSI-18 subscale somatization showing a decreasing trend in patients with BD compared to controls. No time effects in BSI-18 subscales or COVID-19 fears/emotional distress due to social distancing were observed. Regression analyses showed that COVID-19 fears during lockdown predicted somatization, only in patients. There was a connection between the lockdown measures and somatization symptoms observed in patients. When the first steps of easing the social restrictions in May 2020 took place, somatization decreased only in the bipolar compared to the control group. Higher COVID-19 fears during lockdown predicted later symptoms at post-lockdown. Long-term impacts of the COVID-19 pandemic need further investigations to improve current therapeutic approaches and prevent fears and distress during lockdown in individuals with bipolar disorder in times of crisis.
Tài liệu tham khảo
Altman EG, Hedeker D, Peterson JL, Davis JM. The Altman self-rating mania scale. Biol Psychiat. 1997;42(10):948–55. https://doi.org/10.1016/s0006-3223(96)00548-3.
Barzilay R, Moore TM, Greenberg DM, DiDomenico GE, Brown LA, White LK, Gur RE. Resilience, COVID-19-related stress, anxiety and depression during the pandemic in a large population enriched for healthcare providers. Transl Psychiatry. 2020;10(1):1–8.
Bender RE, Alloy LB. Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories. Clin Psychol Rev. 2011;31(3):383–98.
Bengesser S, Reininghaus E. Polygenic risk scores and bipolar disorder. J Psychiatry Brain Sci. 2018;3(6):1–11.
Brietzke E, Mansur RB, Soczynska J, Powell AM, McIntyre RS. A theoretical framework informing research about the role of stress in the pathophysiology of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(1):1–8.
Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–20. https://doi.org/10.1016/s0140-6736(20)30460-8.
Carmassi C, Bertelloni CA, Dell’Oste V, Barberi FM, Maglio A, Buccianelli B, Cordone A, Dell’Osso L. Tele-psychiatry assessment of post-traumatic stress symptoms in 100 patients with bipolar disorder during the COVID-19 Pandemic social-distancing measures in Italy. Front Psychiatry. 2020. https://doi.org/10.3389/fpsyt.2020.580736.
Chang KC, Hou WL, Pakpour AH, Lin CY, Griffiths MD. Psychometric testing of three COVID-19-related scales among people with mental illness. Int J Ment Heal Addict. 2020. https://doi.org/10.1007/s11469-020-00361-6.
Cohen JE. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates Inc; 1988.
Costa M, Pavlo A, Reis G, Ponte K, Davidson L. COVID-19 concerns among persons with mental illness. Psychiatr Serv. 2020;71(11):1188–90. https://doi.org/10.1176/APPI.PS.202000245.
Courtet P, Olié E, Debien C, Vaiva G. Keep socially (but not physically) connected and carry on: preventing suicide in the age of COVID-19. J Clin Psychiatr. 2020;81(3):1–3.
Dalkner N, Bengesser S, Birner A, Rieger A, Seebauer J, Platzer M, Hamm C, Maget A, Queissner R, Pilz R, Fellendorf F, Reininghaus B, Strassnig M, Kapfhammer HP, Reininghaus EZ. Body mass index predicts decline in executive function in bipolar disorder: preliminary data of a 12-month follow-up study. Neuropsychobiology. 2020;80:1–11.
Derogatis LR, Fitzpatrick M. The SCL-90-R, the brief symptom inventory (BSI), and the BSI-18. In: Maruish ME, editor. The use of psychological testing for treatment planning and outcomes assessment: instruments for adults. Hillsdale: Lawrence Erlbaum Associates Publishers; 2004. p. 1–41.
Derogatis LR, Unger R. Symptom checklist-90-revised. In: Weiner IB, Craighead WE, editors. The Corsini encyclopedia of psychology. Hoboken: Wiley; 2010. p. 1–2. https://doi.org/10.1002/9780470479216.corpsy0970.
Dsouza DD, Quadros S, Hyderabadwala ZJ, Mamun MA. Aggregated COVID-19 suicide incidences in India: fear of COVID-19 infection is the prominent causative factor. Psychiatr Res. 2020;290:e113145.
Edgcomb JB, Kerner B. Predictors and outcomes of somatization in bipolar I disorder: a latent class mixture modeling approach. J Affect Disord. 2018;227:681–7. https://doi.org/10.1016/j.jad.2017.11.083.
Edgcomb JB, Tseng CH, Kerner B. Medically unexplained somatic symptoms and bipolar spectrum disorders: a systematic review and meta-analysis. J Affect Disord. 2016;204:205–13.
Esterwood E, Saeed SA. Past epidemics, natural disasters, COVID19, and mental health: learning from history as we deal with the present and prepare for the future. Psychiatr Q. 2020. https://doi.org/10.1007/s11126-020-09808-4.
Evans L, Akiskal HS, Keck PE Jr, McElroy SL, Sadovnick AD, Remick RA, Kelsoe JR. Familiality of temperament in bipolar disorder: support for a genetic spectrum. J Affect Disord. 2005;85(1–2):153–68. https://doi.org/10.1016/j.jad.2003.10.015.
Fatke B, Hölzle P, Frank A, Förstl H. Psychische probleme in der pandemie–beobachtungen während der COVID-19-krise. DMW. 2020;145(10):675–81. https://doi.org/10.1055/a-1147-2889.
Frank A, Fatke B, Frank W, Förstl H, Hölzle P. Depression, dependence and prices of the COVID-19-Crisis. Brain Behav Immun. 2020. https://doi.org/10.1016/j.bbi.2020.04.068.
Franke GH, Jaeger S, Glaesmer H, Barkmann C, Petrowski K, Braehler E. Psychometric analysis of the brief symptom inventory 18 (BSI-18) in a representative German sample. BMC Med Res Methodol. 2017;17(1):14.
González-Blanco L, Dal Santo F, García-Álvarez L, de la Fuente-Tomás L, Lacasa CM, Paniagua G, et al. COVID-19 lockdown in people with severe mental disorders in Spain: do they have a specific psychological reaction compared with other mental disorders and healthy controls? Schizophr Res. 2020;223:192–8. https://doi.org/10.1016/j.schres.2020.07.01.
Greenwood TA, Akiskal HS, Akiskal KK, Study BG, Kelsoe JR. Genome-wide association study of temperament in bipolar disorder reveals significant associations with three novel Loci. Biol Psychiat. 2012;72(4):303–10. https://doi.org/10.1016/j.biopsych.2012.01.018.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JXB, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. https://doi.org/10.1056/nejmoa2002032.
Hansen PS, Laursen MF, Grøntved S, StraszekLicht SPVRW, Nielsen RE. Increasing mortality gap for patients diagnosed with bipolar disorder—a nationwide study with 20 years of follow-up. Bipolar Disord. 2019;21(3):270–5. https://doi.org/10.1111/bdi.12684.
Hao F, Tan W, Jiang L, Zhang L, Zhao X. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav Immun. 2020. https://doi.org/10.1016/j.bbi.2020.04.069.
Ho CS, Chee CY, Ho RC. Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic. Ann Acad Med Singap. 2020;49(1):1–3.
Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, Ford T. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. The Lancet Psychiatry. 2020;7:547–60. https://doi.org/10.1016/s2215-0366(20)30168-1.
Iasevoli F, Fornaro M, D’Urso G, Galletta D, Casella C, Paternoster M, et al. Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy. Psychol Med. 2020. https://doi.org/10.1017/S0033291720001841.
Johns Hopkins University. (2020). COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://coronavirus.jhu.edu/map.html. Accessed 28 Sept 2020.
Klomek AB. Suicide prevention during the COVID-19 outbreak. The Lancet Psychiatry. 2020;7(5):390.
Kühner C, Bürger C, Keller F, Hautzinger M. Reliability and validity of the revised beck depression inventory (BDI-II). Results from German samples. Der Nervenarzt. 2007;78(6):651–6.
Lieberman L, Petrey K, Shankman SA, Phan KL, Gorka SM. Heightened reactivity to uncertain threat as a neurobehavioral marker of suicidal ideation in individuals with depression and anxiety. Int J Psychophysiol. 2020;155:99–104. https://doi.org/10.1016/j.ijpsycho.2020.06.003.
Malkoff-Schwartz S, Frank E, Anderson BP, Hlastala SA, Luther JF, Sherrill JT, et al. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med. 2000;30(5):1005–16.
Mamun MA, Griffiths MD. First COVID-19 suicide case in Bangladesh due to fear of COVID-19 and xenophobia: possible suicide prevention strategies. Asian J Psychiatr. 2020;51:102073.
McIntyre RS, Soczynska JK, Beyer JL, Woldeyohannes HO, Law CW, Miranda A, et al. Medical comorbidity in bipolar disorder: reprioritizing unmet needs. Curr Opin Psychiatry. 2007;20(4):406–16.
Murru A, Manchia M, Hajek T, Nielsen RE, Rybakowski JK, Sani G, et al. Lithium’s antiviral effects: a potential drug for CoViD-19 disease. Int J Bipolar Disord. 2020;8:1–9.
Muruganandam P, Neelamegam S, Menon V, Alexander J, Chaturvedi SK. COVID-19 and severe mental illness: impact on patients and its relation with their awareness about COVID-19. Psychiatry Res. 2020;291:113265. https://doi.org/10.1016/j.psychres.2020.113265.
Nowak JK, Walkowiak J. Lithium and coronaviral infections. A scoping review. F1000Research. 2020. https://doi.org/10.12688/f1000research.22299.2.
Nussmayr K. 15 Grafiken, die die Verbreitung des Coronavirus in Österreich und der Welt erklären. Die Presse. 2020. https://www.diepresse.com/5785804/15-grafiken-die-die-verbreitung-des-coronavirus-in-osterreich-und-der-welt-erklaren. Accessed 29 Sept 2020.
Orhan M, Korten N, Paans N, de Walle B, Kupka R, van Oppen P, Kok A, Sonnenberg C, Schouws S, Dols A. Psychiatric symptoms during the COVID-19 outbreak in older adults with bipolar disorder. Int J Geriatr Psychiatry. 2020. https://doi.org/10.1002/gps.548910.1002/gps.5489.
Pan KY, Kok AA, Eikelenboom M, Horsfall M, Jörg F, Luteijn RA, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. The Lancet Psychiatry. 2020;0366:1–9. https://doi.org/10.1016/S2215-0366(20)30491-0.
Pavlova B, Perlis RH, Alda M, Uher R. Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis. The Lancet Psychiatry. 2015;2(8):710–7. https://doi.org/10.1016/s2215-0366(15)00112-1.
Pérez-Fuentes MDC, Jurado MDMM, Martínez ÁM, Linares JJG. Threat of COVID-19 and emotional state during quarantine: positive and negative affect as mediators in a cross-sectional study of the Spanish population. PLoS ONE. 2020;15(6):e0235305. https://doi.org/10.1371/journal.pone.0235305.
Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. N Engl J Med. 2020;383:510–2. https://doi.org/10.1056/nejmp2008017.
Rajkumar RP. COVID-19 and mental health: a review of the existing literature. Asian J Psychiatr. 2020;52:102066. https://doi.org/10.1016/j.ajp.2020.102066.
Riblet NB, Stevens SP, Shiner B, Cornelius S, Forehand J, Scott RC, Watts BV. Longitudinal examination of COVID-19 public health measures on mental health for rural patients with serious mental illness. Mil Med. 2020. https://doi.org/10.1093/milmed/usaa559.
Rossi R, Socci V, Talevi D, Mensi S, Niolu C, Pacitti F, et al. COVID-19 pandemic and lockdown measures impact on mental health among the general population in Italy. Front Psychiatry. 2020;11:790. https://doi.org/10.3389/fpsyt.2020.00790.
Semo BW, Frissa SM. The mental health impact of the COVID-19 pandemic: implications for sub-Saharan Africa. Psychol Res Behav Manag. 2020;13:713.
Sher L. The impact of the COVID-19 pandemic on suicide rates. QJM. 2020;10:707–12.
Solé B, Verdolini N, Amoretti S, Montejo L, Rosa AR, Hogg B, et al. Effects of the COVID-19 pandemic and lockdown in Spain: comparison between community controls and patients with a psychiatric disorder. Preliminary results from the BRIS-MHC STUDY. J Affect Disord. 2021;281:13–23. https://doi.org/10.1016/j.jad.2020.11.099.
Stefana A, Youngstrom EA, Jun C, Hinshaw S, Maxwell V, Michalak E, Vieta E. The COVID-19 pandemic is a crisis and opportunity for bipolar disorder. Bipolar Disord. 2020;22:641–3. https://doi.org/10.1111/bdi.12949.
Szentagotai A, David D. The efficacy of cognitive-behavioral therapy in bipolar disorder: a quantitative meta-analysis. J Clin Psychiatry. 2009;71(1):66–72.
Taylor SE, Lerner JS, Sage RM, Lehman BJ, Seeman TE. Early environment, emotions, responses to stress, and health. J Pers. 2004;72(6):1365–94. https://doi.org/10.1111/j.1467-6494.2004.00300.x.
Torous J, Wykes T. Opportunities from the coronavirus disease 2019 pandemic for transforming psychiatric care with telehealth. JAMA Psychiat. 2020;11:e1-2. https://doi.org/10.1001/jamapsychiatry.2020.1640.
Tull MT, Edmonds KA, Scamaldo K, Richmond JR, Rose JP, Gratz KL. Psychological outcomes associated with stay-at-home orders and the perceived impact of COVID-19 on daily life. Psychiatry Res. 2020;289:1–6.
Van Rheenen TE, Meyer D, Neill E, Phillipou A, Tan EJ, Toh WL, Rossell SL. Mental health status of individuals with a mood-disorder during the COVID-19 pandemic in Australia: initial results from the COLLATE project. J Affect Disord. 2020;275:69–77. https://doi.org/10.1016/j.jad.2020.06.037.
Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013;170(3):265–74. https://doi.org/10.1176/appi.ajp.2012.12050620.
Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15(2):166–74. https://doi.org/10.1002/wps.20309.
Vieta E, Berk M, Birmaher B, Grande I. Bipolar disorder: defining symptoms and comorbidities–authors’ reply. The Lancet. 2016;388(10047):869–70. https://doi.org/10.1016/S0140-6736(16)30966-7.
Wagner-Skacel J, Bengesser S, Dalkner N, Mörkl S, Painold A, Hamm C, et al. Personality structure and attachment in bipolar disorder. Front Psych. 2020;11:410. https://doi.org/10.3389/fpsyt.2020.00410.
Weiss RB, Stange JP, Boland EM, Black SK, LaBelle DR, Abramson LY, Alloy LB. Kindling of life stress in bipolar disorder: comparison of sensitization and autonomy models. J Abnorm Psychol. 2015;124(1):4.
Williams JMG, Alatiq Y, Crane C, Barnhofer T, Fennell MJ, Duggan DS, et al. Mindfulness-based cognitive therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning. J Affect Disord. 2008;107(1–3):275–9.
Wind TR, Rijkeboer M, Andersson G, Riper H. The COVID-19 pandemic: the ‘black swan’ for mental health care and a turning point for e-health. Internet Interv. 2020;100317:1–2. https://doi.org/10.1016/j.invent.2020.100317.
Wu W, Zhang Y, Wang P, Zhang L, Wang G, Lei G, et al. Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy. J Med Virol. 2020;92:1962–70.
Yao H, Chen JH, Xu YF. Patients with mental health disorders in the COVID-19 epidemic. The Lancet Psychiatry. 2020;7(4):e21. https://doi.org/10.1016/s2215-0366(20)30090-0.
Youngstrom EA, Hinshaw SP, Stefana A, Chen J, Michael K, Van Meter A, et al. Working with bipolar disorder during the COVID-19 pandemic: both crisis and opportunity. Wiki J Med. 2020;7(1):4. https://doi.org/10.31234/osf.io/wg4bj.
Zandifar A, Badrfam R. Iranian mental health during the COVID-19 epidemic. Asian J Psychiatr. 2020;51:101990. https://doi.org/10.1016/j.ajp.2020.101990.
Zareifopoulos N, Bellou A, Spiropoulou A, Spiropoulos K. Prevalence of comorbid chronic obstructive pulmonary disease in individuals suffering from schizophrenia and bipolar disorder: a systematic review. COPD. 2018;15(6):612–20. https://doi.org/10.1080/15412555.2019.1572730.
Zhou X, Snoswell CL, Harding LE, Bambling M, Edirippulige S, Bai X, et al. The role of telehealth in reducing the mental health burden from COVID-19. Telemed e-Health. 2020;26(4):377–9. https://doi.org/10.1089/tmj.2020.0068.
Zou S, Liu ZH, Yan X, Wang H, Li Y, Xu X, et al. Prevalence and correlates of fatigue and its association with quality of life among clinically stable older psychiatric patients during the COVID-19 outbreak: a cross-sectional study. Glob Health. 2020;16(1):1–7.